135 related articles for article (PubMed ID: 15475005)
1. Runx2/Cbfa1 stimulates transdifferentiation of primary skeletal myoblasts into a mineralizing osteoblastic phenotype.
Gersbach CA; Byers BA; Pavlath GK; García AJ
Exp Cell Res; 2004 Nov; 300(2):406-17. PubMed ID: 15475005
[TBL] [Abstract][Full Text] [Related]
2. Identification of potential modifiers of Runx2/Cbfa1 activity in C2C12 cells in response to bone morphogenetic protein-7.
Gu K; Zhang L; Jin T; Rutherford RB
Cells Tissues Organs; 2004; 176(1-3):28-40. PubMed ID: 14745233
[TBL] [Abstract][Full Text] [Related]
3. Synergistic effects of Nell-1 and BMP-2 on the osteogenic differentiation of myoblasts.
Cowan CM; Jiang X; Hsu T; Soo C; Zhang B; Wang JZ; Kuroda S; Wu B; Zhang Z; Zhang X; Ting K
J Bone Miner Res; 2007 Jun; 22(6):918-30. PubMed ID: 17352654
[TBL] [Abstract][Full Text] [Related]
4. Transcriptional regulation of the human Runx2/Cbfa1 gene promoter by bone morphogenetic protein-7.
Tou L; Quibria N; Alexander JM
Mol Cell Endocrinol; 2003 Jul; 205(1-2):121-9. PubMed ID: 12890574
[TBL] [Abstract][Full Text] [Related]
5. Transient upregulation of CBFA1 in response to bone morphogenetic protein-2 and transforming growth factor beta1 in C2C12 myogenic cells coincides with suppression of the myogenic phenotype but is not sufficient for osteoblast differentiation.
Lee MH; Javed A; Kim HJ; Shin HI; Gutierrez S; Choi JY; Rosen V; Stein JL; van Wijnen AJ; Stein GS; Lian JB; Ryoo HM
J Cell Biochem; 1999 Apr; 73(1):114-25. PubMed ID: 10088730
[TBL] [Abstract][Full Text] [Related]
6. MyoD enhances BMP7-induced osteogenic differentiation of myogenic cell cultures.
Komaki M; Asakura A; Rudnicki MA; Sodek J; Cheifetz S
J Cell Sci; 2004 Mar; 117(Pt 8):1457-68. PubMed ID: 15020674
[TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo osteoblastic differentiation of BMP-2- and Runx2-engineered skeletal myoblasts.
Gersbach CA; Guldberg RE; García AJ
J Cell Biochem; 2007 Apr; 100(5):1324-36. PubMed ID: 17131362
[TBL] [Abstract][Full Text] [Related]
8. Runx2/Cbfa1-genetically engineered skeletal myoblasts mineralize collagen scaffolds in vitro.
Gersbach CA; Byers BA; Pavlath GK; Guldberg RE; García AJ
Biotechnol Bioeng; 2004 Nov; 88(3):369-78. PubMed ID: 15486943
[TBL] [Abstract][Full Text] [Related]
9. Exogenous Runx2 expression enhances in vitro osteoblastic differentiation and mineralization in primary bone marrow stromal cells.
Byers BA; García AJ
Tissue Eng; 2004; 10(11-12):1623-32. PubMed ID: 15684671
[TBL] [Abstract][Full Text] [Related]
10. BMP signaling is required for RUNX2-dependent induction of the osteoblast phenotype.
Phimphilai M; Zhao Z; Boules H; Roca H; Franceschi RT
J Bone Miner Res; 2006 Apr; 21(4):637-46. PubMed ID: 16598384
[TBL] [Abstract][Full Text] [Related]
11. Runx2 overexpression enhances osteoblastic differentiation and mineralization in adipose--derived stem cells in vitro and in vivo.
Zhang X; Yang M; Lin L; Chen P; Ma KT; Zhou CY; Ao YF
Calcif Tissue Int; 2006 Sep; 79(3):169-78. PubMed ID: 16969589
[TBL] [Abstract][Full Text] [Related]
12. Cyclic stretch enhances bone morphogenetic protein-2-induced osteoblastic differentiation through the inhibition of Hey1.
Zeng Z; Yin X; Zhang X; Jing D; Feng X
Int J Mol Med; 2015 Nov; 36(5):1273-81. PubMed ID: 26647760
[TBL] [Abstract][Full Text] [Related]
13. Regulatory controls for osteoblast growth and differentiation: role of Runx/Cbfa/AML factors.
Lian JB; Javed A; Zaidi SK; Lengner C; Montecino M; van Wijnen AJ; Stein JL; Stein GS
Crit Rev Eukaryot Gene Expr; 2004; 14(1-2):1-41. PubMed ID: 15104525
[TBL] [Abstract][Full Text] [Related]
14. Intimate relationship between TGF-beta/BMP signaling and runt domain transcription factor, PEBP2/CBF.
Bae SC; Lee KS; Zhang YW; Ito Y
J Bone Joint Surg Am; 2001; 83-A Suppl 1(Pt 1):S48-55. PubMed ID: 11263665
[TBL] [Abstract][Full Text] [Related]
15. FHL2 mediates dexamethasone-induced mesenchymal cell differentiation into osteoblasts by activating Wnt/beta-catenin signaling-dependent Runx2 expression.
Hamidouche Z; Haÿ E; Vaudin P; Charbord P; Schüle R; Marie PJ; Fromigué O
FASEB J; 2008 Nov; 22(11):3813-22. PubMed ID: 18653765
[TBL] [Abstract][Full Text] [Related]
16. Beta-catenin and BMP-2 synergize to promote osteoblast differentiation and new bone formation.
Mbalaviele G; Sheikh S; Stains JP; Salazar VS; Cheng SL; Chen D; Civitelli R
J Cell Biochem; 2005 Feb; 94(2):403-18. PubMed ID: 15526274
[TBL] [Abstract][Full Text] [Related]
17. Multiple mechanisms are involved in inhibition of osteoblast differentiation by PTHrP and PTH in KS483 Cells.
van der Horst G; Farih-Sips H; Löwik CW; Karperien M
J Bone Miner Res; 2005 Dec; 20(12):2233-44. PubMed ID: 16294276
[TBL] [Abstract][Full Text] [Related]
18. Simvastatin antagonizes tumor necrosis factor-alpha inhibition of bone morphogenetic proteins-2-induced osteoblast differentiation by regulating Smad signaling and Ras/Rho-mitogen-activated protein kinase pathway.
Yamashita M; Otsuka F; Mukai T; Otani H; Inagaki K; Miyoshi T; Goto J; Yamamura M; Makino H
J Endocrinol; 2008 Mar; 196(3):601-13. PubMed ID: 18310456
[TBL] [Abstract][Full Text] [Related]
19. Pitx2 prevents osteoblastic transdifferentiation of myoblasts by bone morphogenetic proteins.
Hayashi M; Maeda S; Aburatani H; Kitamura K; Miyoshi H; Miyazono K; Imamura T
J Biol Chem; 2008 Jan; 283(1):565-571. PubMed ID: 17951577
[TBL] [Abstract][Full Text] [Related]
20. Changes in Runx2/Cbfa1 expression and activity during osteoblastic differentiation of human bone marrow stromal cells.
Shui C; Spelsberg TC; Riggs BL; Khosla S
J Bone Miner Res; 2003 Feb; 18(2):213-21. PubMed ID: 12568398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
